Trump Orders Fast Psychedelics Review
April 24, 2026·about 2 hours ago·via News Channel 5 Nashville

Trump signs executive order accelerating FDA review of psychedelics like controversial ibogaine, unleashing innovation against Big Pharma's stranglehold and government red tape. This pro-liberty push targets PTSD and addiction treatments, empowering veterans and everyday Americans with cutting-edge therapies long suppressed by bureaucrats. While libs clutch pearls over "drugs," Trump's move champions personal freedom and medical breakthroughs over nanny-state control. Read more about this...